Continuing Medical Education
![](/images/Oa.jpg)
Thalassaemia (part 2): Management
Abstract
Authors' affiliations
N A Alli, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa
M Patel, Department of Medicine, Chris Hani Baragwanath Academic Hospital and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
J Poole, Department of Paediatrics and Child Health, Paediatric Haematology/Oncology Unit, Faculty of Health Sciences, University of the Witwatersrand and Charlotte Maxeke Hospital, Johannesburg, South Africa
Y Goga, Department of Paediatrics and Child Health, Nelson R Mandela School of Medicine, University of KwaZulu-Natal and Inkosi Albert Luthuli Central Hospital, Durban, South Africa
F Fazel, Blood Centre, Rondebosch Medical Centre, Cape Town, South Africa
N Novitzky, Division of Clinical Haematology, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Tygerberg Academic Hospital and Stellenbosch University, Cape Town, South Africa
S Parasnath, Department of Clinical Haematology, Inkosi Albert Luthuli Central Hospital and Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
F Bassa, Division of Clinical Haematology, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Tygerberg Academic Hospital and Stellenbosch University, Cape Town, South Africa
Full Text
![](/images/icons/PDF.png)
Keywords
Cite this article
Article History
Date published: 2021-09-02
Article Views
Full text views: 952
Comments on this article
*Read our policy for posting comments here